Holoclara

Project focused on worm-derived therapies for allergic and autoimmune disease

placeLos Angeles, California, United States calendar_todayFounded 2017 groups6 employees language holoclara.com

Social engagement

Social engagement: 953 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Bold Capital Partners.

Investor typeCountShare
Venture capital563%
Accelerator & incubator113%
Other / undisclosed225%
Coming soon